(19)
(11) EP 2 844 310 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
08.11.2017 Bulletin 2017/45

(45) Mention of the grant of the patent:
06.09.2017 Bulletin 2017/36

(21) Application number: 13729450.0

(22) Date of filing: 02.05.2013
(51) International Patent Classification (IPC): 
A61L 27/60(2006.01)
A61L 27/38(2006.01)
 C08B 37/00(2006.01)
(86) International application number:
PCT/IB2013/053475
(87) International publication number:
WO 2013/164782 (07.11.2013 Gazette 2013/45)

(54)

SHAPE-MEMORY CROSS-LINKED POLYSACCHARIDES

VERNETZTE FORMGEDÄCHTNISPOLYSACCHARIDE

POLYSACCHARIDES RÉTICULÉS À MÉMOIRE DE FORME

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 03.05.2012 IT MI20120732

(43) Date of publication of application:
11.03.2015 Bulletin 2015/11

(73) Proprietor: Medical and Biotechnological Consultants in sigla M.B.C. S.r.l.
82100 Benevento (IT)

(72) Inventors:
  • DE ROSA, Mario
    I-83100 Avellino (IT)
  • SCHIRALDI, Chiara
    I-83100 Avellino (IT)
  • LA GATTA, Annalisa
    I-83100 Avellino (IT)

(74) Representative: Minoja, Fabrizio 
Bianchetti Bracco Minoja S.r.l. Via Plinio, 63
20129 Milano
20129 Milano (IT)


(56) References cited: : 
WO-A2-2011/023355
US-A1- 2010 028 435
 CN-A- 102 321 258
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).